Get a Demo

1 min read

Whitepaper: 3 Ways to Fail TMF Inspection

Featured Image

TMF inspections have changed quite a bit in recent years. At the basic level, collaboration, preparation, maintenance, and inspection of the TMF is no longer a centralized effort – partly because teams have gone remote and inspections have gone virtual. 

This whitepaper will cover these key topics:

  • What are the 3 most common points of failure for the TMF inspection?
  • How to mitigate these pitfalls 
  • 7 steps to help your team prepare - and pass - inspection

Here is a short sample from the whitepaper...to view the complete guide, fill out the form below

3 Ways Organizations Fail TMF Virtual Inspections

Build a process for inspection-ready submissions and avoid these mistakes

The Trial Master File (TMF) conveys a study’s chronology, and regulatory agencies worldwide view the TMF as a barometer of study health and compliance with Good Clinical Practice (GCP). For this reason, companies undertaking a clinical trial, whether a large or a small clinical study, understand the necessity of agents scrutinizing the Trial Master File, inch by inch, while ensuring compliance. Just as importantly, while the focus of the TMF inspection ultimately drives the method or approach of the review, teams should expect that aspects of it will be conducted virtually from here on out.

Because of today’s disconnected global landscape, remote inspections are challenging. TMFs are often managed in different locations, with content usually spread across other systems. For remote inspections to be successful, they need a single path to compliance; they need TMF management and storage centralization, with one or several interconnected systems that an inspector can access.

While it’s true, the industry, as a whole, is making an undeniable effort to move towards more modern tools for powering their clinical programs. It’s also true that many life sciences companies still support and maintain legacy applications. To secure favorable results in your TMF inspection, sponsors need a more robust and modern eTMF system that supports virtual assessment for the inspectors. 

 Following are the three most probable ways your Trial Master File will fail a virtual inspection:

1. Lack of required documents

One of the most common reasons Trial Master Files fail during an inspection is a lack of essential records, leaving inspectors unable to reconstruct the narrative of the trial. If teams fail to...

Want to read more? Complete the form below 👇

 

Download the Whitepaper

 

PMA Submission Guide: FDA Requirements, Timelines, and Best Practices

For medical device manufacturers, the Premarket Approval (PMA) process is the most rigorous path to market in the United States. Reserved for Class III devices that sustain life, prevent...

1 October 2025
7 min read

Biologics License Application (BLA) Guide For Life Sciences Teams

A Biologics License Application (BLA) is one of the most critical milestones in the development of a biologic therapy. It is the formal request submitted to the U.S. Food and Drug...

1 October 2025
8 min read

ANDA Application Guide For Modern Life Sciences Teams

Generic drugs play a critical role in improving patient access and reducing healthcare costs. But bringing a generic to market is not a simple process. Companies must demonstrate that their...

30 September 2025
4 min read

PMA Submission Guide: FDA Requirements, Timelines, and Best Practices

For medical device manufacturers, the Premarket Approval (PMA) process is the most rigorous path to market in the United States. Reserved for Class III devices that sustain life, prevent...

1 October 2025
7 min read

Biologics License Application (BLA) Guide For Life Sciences Teams

A Biologics License Application (BLA) is one of the most critical milestones in the development of a biologic therapy. It is the formal request submitted to the U.S. Food and Drug...

1 October 2025
8 min read

ANDA Application Guide For Modern Life Sciences Teams

Generic drugs play a critical role in improving patient access and reducing healthcare costs. But bringing a generic to market is not a simple process. Companies must demonstrate that their...

30 September 2025
4 min read